32.66
3.06%
1.51
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$31.15
Offen:
$31.61
24-Stunden-Volumen:
215.22K
Relative Volume:
0.06
Marktkapitalisierung:
$4.90B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-116.64
EPS:
-0.28
Netto-Cashflow:
$67.82M
1W Leistung:
+4.08%
1M Leistung:
+31.73%
6M Leistung:
+93.39%
1J Leistung:
+160.57%
Tg Therapeutics Inc Stock (TGTX) Company Profile
Firmenname
Tg Therapeutics Inc
Sektor
Branche
Telefon
(212) 554-4484
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Vergleichen Sie TGTX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
TGTX | 32.46 | 4.90B | 264.79M | -14.36M | 67.82M | -0.28 |
VRTX | 447.95 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 741.90 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 590.56 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 249.60 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 102.56 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-08-02 | Hochstufung | Goldman | Sell → Neutral |
2023-06-26 | Fortgesetzt | Jefferies | Buy |
2022-05-20 | Eingeleitet | BofA Securities | Underperform |
2022-02-23 | Bestätigt | B. Riley Securities | Buy |
2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
2021-04-20 | Eingeleitet | Goldman | Neutral |
2021-04-19 | Bestätigt | H.C. Wainwright | Buy |
2020-09-01 | Eingeleitet | JP Morgan | Overweight |
2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
2020-06-05 | Eingeleitet | Evercore ISI | Outperform |
2020-01-17 | Bestätigt | H.C. Wainwright | Buy |
2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
2019-02-06 | Fortgesetzt | Jefferies | Buy |
2018-09-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
2018-03-09 | Bestätigt | B. Riley FBR, Inc. | Buy |
2017-12-01 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
2017-11-14 | Fortgesetzt | H.C. Wainwright | Buy |
2017-04-25 | Eingeleitet | Jefferies | Buy |
2017-03-06 | Bestätigt | FBR & Co. | Outperform |
2016-10-06 | Fortgesetzt | Brean Capital | Buy |
2016-05-27 | Eingeleitet | SunTrust | Buy |
2015-12-01 | Eingeleitet | FBR Capital | Outperform |
2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
2015-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
2015-06-19 | Bestätigt | Brean Capital | Buy |
2014-12-11 | Bestätigt | ROTH Capital | Buy |
2014-12-10 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
TG Therapeutics Ranked Number One Fastest-Growing Company - GlobeNewswire
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - Yahoo Finance
Oppenheimer & Co. Inc. Acquires New Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
State of New Jersey Common Pension Fund D Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
When (TGTX) Moves Investors should Listen - Stock Traders Daily
Entropy Technologies LP Purchases Shares of 31,200 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Amalgamated Bank - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Los Angeles Capital Management LLC - MarketBeat
Insider Sale: Director Laurence Charney Sells 25,000 Shares of T - GuruFocus.com
Insider Sale: Director Sagar Lonial Sells 5,000 Shares of TG The - GuruFocus.com
New York State Teachers Retirement System Invests $1 Million in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Don't Ignore The Insider Selling In TG Therapeutics - Simply Wall St
TG Therapeutics stock hits 52-week high at $28.43 - Investing.com India
TG Therapeutics stock hits 52-week high at $28.43 By Investing.com - Investing.com Canada
FY2024 EPS Estimates for TG Therapeutics Raised by Analyst - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Sets New 1-Year HighWhat's Next? - MarketBeat
FY2027 EPS Forecast for TG Therapeutics Decreased by Analyst - MarketBeat
Optimistic Investors Push TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Up 27% But Growth Is Lacking - Simply Wall St
TG Therapeutics, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
FY2024 EPS Estimates for TG Therapeutics Lowered by Analyst - MarketBeat
HC Wainwright Boosts Earnings Estimates for TG Therapeutics - MarketBeat
TG Therapeutics Inc (TGTX) Q3 2024 Earnings: Revenue Hits $83.3M, EPS at $0.02, Surpassing Estimates - GuruFocus.com
HC Wainwright Increases TG Therapeutics (NASDAQ:TGTX) Price Target to $55.00 - MarketBeat
TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $22.00 at The Goldman Sachs Group - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Announces Earnings Results - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript - Insider Monkey
TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Rec - GuruFocus.com
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Earnings call: TG Therapeutics reports robust growth for BRIUMVI - Investing.com
TG Therapeutics: Q3 Earnings Snapshot - Darien Times
Earnings call: TG Therapeutics reports robust growth for BRIUMVI By Investing.com - Investing.com UK
TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here’s Why Shares Fell - Seeking Alpha
TG Therapeutics (TGTX) Lags Q3 Earnings Estimates - MSN
(TGTX) Trading Advice - Stock Traders Daily
FUJIFILM Diosynth Biotechnologies To Manufacture TG Therapeutics' MS Drug - Contract Pharma
TG Therapeutics (NASDAQ:TGTX) Shares Gap DownHere's What Happened - MarketBeat
Morning Brew: Nvidia Joins Dow, Fed Rate Cut Looms, and TG Thera - GuruFocus.com
FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics - The Manila Times
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance - The Manila Times
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Increased by Raymond James & Associates - Defense World
TG Therapeutics Reports Third Quarter 2024 Financial - GlobeNewswire
TG Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought by Raymond James & Associates - MarketBeat
State of Alaska Department of Revenue Acquires Shares of 76,130 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):